2016;21:675 97. 107. Greene SJ, Fonarow GC, DeVore AD, et al. Titra- tion of medical therapy for heart failure with reduced ejection fraction. J Am Coll Cardiol. 2019;73:2365 83. 108. Garavalia L, Garavalia B, Spertus JA, et al. Exploring patients reasons for discontinuance of heart medications. J Cardiovasc Nurs. 2009;24:371 9. 109. Dolansky MA, Hawkins MA, Schaefer JT, et al. Association between poorer cognitive function and reduced objectively monitored medication adherence in patients with heart failure. Circ Heart Fail. 2016;9: e002475. 110. Unni EJ, Farris KB. Unintentional non-adherence and belief in medicines in older adults. Patient Educ Couns. 2011;83:265 8. 111. World Health Organization. Adherence to long- term therapies: evidence for action. Available at: http://www.who.int/chp/knowledge/publications/ adherence_report/en/. Accessed September 1, 2020. 112. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028 35. 113. Masoudi FA, Baillie CA, Wang Y, et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005;165:2069 76. 114. Allen LA, Fonarow GC, Liang L, et al. Medication initiation burden required to comply with heart failure guideline recommendations and hospital quality mea- sures. Circulation. 2015;132:1347 53. 115. Fumagalli LP, Radaelli G, Lettieri E, et al. Patient empowerment and its neighbours: clarifying the boundaries and their mutual relationships. Health Policy. 2015;119:384 94. 116. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988;15:175 83. 117. Bandura A. Human agency in social cognitive theory. Am Psychol. 1989;44:1175 84. 118. Conn VS, Ruppar TM. Medication adherence out- comes of 771 intervention trials: Systematic review and meta-analysis. Prev Med. 2017;99:269 76. 119. Ruppar TM, Cooper PS, Mehr DR, et al. 